ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,018.39
      -0.34%
      US Tech 100
      16,952.00
      -0.19%
      Dow Jones
      37,903.29
      0.23%
      Brent Oil
      83.605
      0.08%
      Bitcoin
      57,877.27
      -0.62%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Organovo Holdings Inc (ONVO)

      7. Organovo Holdings Inc (ONVO) News

      ONVO

      Organovo (ONVO)

      Organovo Holdings Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ONVO
      DateTimeSourceHeadlineSymbolCompany
      04/15/20248:05AMGlobeNewswire Inc.Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to PlaceboNASDAQ:ONVOOrganovo Holdings Inc
      02/09/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ONVOOrganovo Holdings Inc
      02/08/20244:56PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ONVOOrganovo Holdings Inc
      02/08/20244:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONVOOrganovo Holdings Inc
      02/07/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
      01/26/20245:09PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ONVOOrganovo Holdings Inc
      01/25/20248:05AMGlobeNewswire Inc.Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis CongressNASDAQ:ONVOOrganovo Holdings Inc
      01/09/20248:05AMGlobeNewswire Inc.Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis CongressNASDAQ:ONVOOrganovo Holdings Inc
      12/28/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
      12/22/20236:05AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ONVOOrganovo Holdings Inc
      12/06/20238:05AMGlobeNewswire Inc.Organovo Provides Timing for Release of FXR314 Phase 2 NASH ResultsNASDAQ:ONVOOrganovo Holdings Inc
      12/01/20234:07PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ONVOOrganovo Holdings Inc
      11/17/20236:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
      11/17/20236:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
      11/17/20236:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
      11/17/20236:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
      11/17/20236:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
      11/15/20234:41PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ONVOOrganovo Holdings Inc
      11/13/20238:05AMGlobeNewswire Inc.CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and PlanNASDAQ:ONVOOrganovo Holdings Inc
      11/09/20235:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONVOOrganovo Holdings Inc
      11/08/20238:05AMGlobeNewswire Inc.Organovo Highlights FXR314 Combination Therapy Potential and PlanNASDAQ:ONVOOrganovo Holdings Inc
      11/03/20238:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
      09/22/20234:05PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ONVOOrganovo Holdings Inc
      09/13/20235:07PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ONVOOrganovo Holdings Inc
      09/13/20235:06PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ONVOOrganovo Holdings Inc
      09/13/20235:06PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONVOOrganovo Holdings Inc
      09/12/20234:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
      09/08/202312:46PMGlobeNewswire Inc.Organovo to Participate in the H.C. Wainwright Global Investment ConferenceNASDAQ:ONVOOrganovo Holdings Inc
      09/05/20236:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
      08/23/20238:05AMGlobeNewswire Inc.Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 DataNASDAQ:ONVOOrganovo Holdings Inc
       Showing the most relevant articles for your search:NASDAQ:ONVO